Oncology & Cancer

New drug for metastatic colorectal cancer enters phase 3 trial

A new therapy for metastatic colorectal cancer that has been granted fast-track designation by the U.S. Food and Drug Administration is being tested in a phase 3 clinical trial at Vanderbilt-Ingram Cancer Center.

Medications

Adding omega-3 fatty acids does not cut high CV risk

(HealthDay)—A carboxylic acid formulation of eicosapentaenoic acid and docosahexaenoic acid (omega-3 CA) does not improve outcomes among statin-treated patients at high cardiovascular risk, according to a study published ...

Obstetrics & gynaecology

Ibuprofen does not increase postpartum blood pressure

(HealthDay)—Nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, do not increase blood pressure among postpartum women with hypertensive disorders of pregnancy, according to a study published online Nov. 4 ...

page 1 from 3